Clin2
NCT07118462Possibly a fitRecruiting

Acetazolamide, high altitude, and plasma volume study

High Altitude EffectsHigh Altitude HypoxiaAcute Mountain Sickness (AMS)Plasma VolumeWomen

Treatments studied

Part of Lungs & breathing clinical trials.

This trial tests how acetazolamide affects your body's fluid levels at high altitude. It might help understand if the drug can prevent altitude sickness.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
270 people
Ages
18 years to 44 years
Study type
Interventional

Who can take part

  • You are between 18 and 44 years old and do not smoke.
  • You are generally healthy and don't take any regular medications, including birth control pills.
  • Your body mass index (BMI) is between 18 and 30.
  • You were born, raised, and currently live at an elevation below 1000 meters.
  • If you are a woman of childbearing age, you have regular menstrual cycles and are not pregnant or nursing.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07148674Not yet recruiting
Breathing device for preventing altitude sickness

This trial tests if a breathing tool that creates positive pressure when you exhale can help prevent acute mountain sickness during a climb up Mount Aconcagua in Argentina. It may help people who plan to climb at very high altitudes.

NCT06981234Recruiting· Phase 2
Acetazolamide for type 1 diabetes

This trial tests whether a medicine called acetazolamide (used for altitude sickness) can help people with type 1 diabetes. It compares how your body responds while on the drug versus a placebo, using a crossover design so everyone gets both treatments.

La Jolla, California
NCT07653516Not yet recruiting· Phase 4
Testing a migraine drug for preventing altitude sickness

This trial investigates whether a medication usually used for migraines (fremanezumab) can help prevent acute mountain sickness in healthy adults who travel to high altitudes. You would receive an injection and be monitored for symptoms.

Bern
NCT07199088Recruiting
Comparing two medicines for fluid buildup in heart failure

This study tests whether adding acetazolamide or metolazone to standard treatment helps remove extra fluid better in people hospitalized for heart failure. It aims to find a safer and more effective option for managing fluid overload.

Chak Four Hundred Fifty-four, Punjab Province
NCT07737964Not yet recruiting· Phase 3
Acetazolamide to help heart failure patients lose fluid and feel better

This trial tests if adding acetazolamide (a water pill) to your usual heart failure treatment can help you lose extra fluid and relieve symptoms. It is for patients recently hospitalized or seen urgently for heart failure worsening.

Amiens
NCT05802849Recruiting· Phase 4
Oral acetazolamide for worsening heart failure

This trial tests whether taking acetazolamide by mouth can help prevent or improve worsening (decompensation) of heart failure after you needed IV water pills (diuretics). It’s mainly for adults with a recent heart-failure flare and specific heart/lab signs, while carefully excluding certain low blood pressure, kidney issues, and electrolyte or acid–base problems.

Samara

Hear when a new High Altitude Effects trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.